← FDA ENFORCEMENT
D-0875-2026Class II

TerSera Therapeutics LLC

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
TerSera Therapeutics LLC
Product type
Drug
Status
Ongoing
Report date
2026-10-07
Distribution
USA Nationwide
Firm state
IL
Product quantity
296 cartons
Initiated by
Voluntary: Firm initiated
Reason for recall

Temperature Abuse: Product sat in a non-temperature-controlled FedEx trailer at ambient outdoor conditions for 25.5 hours.

Product description

Zoladex (goserelin) implant, 3.6 mg, One single-Use Syringe packaged in a carton, Rx only, Manufactured for: TerSera therapeutics LLC, Deerfield, IL 60015, BY: AstraZeneca UK Limited, Macclesfield, England, Product of Switzerland, website at www.zoladex.com, NDC 70720-950-36.

Code / lot info

Lot#: YN0099, Exp 01/31/2028

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →